Botox type A for the prevention of POAF in open-chest cardiac surgery
Diseases of the Cardiovascular System
What is the purpose of this trial?
This is a multi-center, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to evaluate the efficacy and safety of botulinum toxin type A (AGN-151607) injections into the epicardial fat pads, foci of ganglionic plexi, to prevent Post-Operative Atrial Fibrillation (POAF) in patients undergoing open-chest cardiac surgery.
- Ages55 years - 90 years
- Trial withAllergan Sales, Inc.
- Start Date05/15/2021
- End Date10/15/2020
- Last Updated05/01/2022
- Study HIC#2000028539